Total Artificial Heart Facts
When both sides of the heart can no longer pump enough blood to sustain the body
(end-stage biventricular failure), vital organs like the kidneys, liver and brain are starved of the blood, oxygen and nutrients they need to function properly. It is a race against time to restore adequate blood flow to the body before tissue dies and vital organs suffer permanent damage. For these critically ill patients, there are two treatment options: an immediate donor heart transplant or the SynCardia temporary Total Artificial Heart as a bridge to transplant.
- Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves.
- Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. ›› learn more
- The Total Artificial Heart is the only device that eliminates the symptoms and source of end-stage biventricular heart failure.
- The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate. ›› learn more
- The longest a patient has been supported with the SynCardia Total Artificial Heart is 1,374 days (nearly four years) prior to receiving a successful heart transplant.
- During 30 years of use, the valves in the SynCardia Total Artificial Heart have never failed. The diaphragm, which is responsible for pumping blood in and out of the ventricles, has a failure rate of less than 1% over more than 1,000 implants (2,000+ diaphragms).
- There have been more than 1,200 implants of the Total Artificial Heart, accounting for more than 335 patient years of support.
- Implanting the Total Artificial Heart eliminates the following native heart complications: ›› learn more
- Arrhythmias, which may require a pacemaker and/or defibrillator. In 2009, 397,000 patients underwent pacemaker-related surgeries and 116,000 underwent surgery for an implantable defibrillator.
- Failing ventricles, which may require medication, a left ventricular assist device (LVAD) or a right ventricular assist device (RVAD)
- Malfunctioning heart valves, which may require surgery to correct or replace. In 2009, 139,000 patients underwent valve surgeries.
(Source: American Heart Association 2012)
- During the 10-year pivotal clinical study, approximately 65% of Total Artificial Heart patients were out of bed by the 5th day after implant. ›› learn more
- In addition, two weeks after implant, 60% of Total Artificial Heart patients were walking more than 100 feet. ›› learn more
- The Total Artificial Heart has the highest bridge to transplant rate of any approved mechanical circulatory support device, 79% ›› learn more
NEXT ›› Donor Heart Facts